https://www.news-medical.net/news/20221031/Ubiquigent-obtains-exclusive-license-for-UbiSite-technology-to-strengthen-its-specialist-drug-discovery-services.aspx
0
0
10/31/22 at 1:30pm
Organization
News-Medical.Net
Authors
Ubiquigent Limited (Ubiquigent), a drug discovery and development company harnessing novel deubiquitylase (DUB) modulators as new therapeutics for areas of high unmet medical need, has signed an exclusive license with the University of Southern Denmark for it…
Create an account
or login to join the discussion